THOMAS RENFRO: Open Payments
NPI 1497726376 · COEBURN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$59 in 3 payments from 2 companies in 2025. Trend: 2023 $373 · 2024 $169 · 2025 $59
Food & beverage: $59
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: CAPLYTA, FARXIGA.
Industry payments across VA — which companies pay providers there.
